Type(s) of Cancer
Prostate
Prostate
Study Phase
Phase 3
Study Completion Date
July 2010
July 2010
NCT00554229Uploaded 10-13-2015
Available for Download
PDS UID: Prostat_AstraZe_2009_144
A Phase III Trial to Test the Efficacy of ZD4054(Zibotentan), an Endothelin A Receptor Antagonist, Versus Placebo in Patients With Hormone Resistant Prostate Cancer (HRPC) and Bone Metastasis Who Are Pain Free and Mildly Symptomatic.
PDS UID: Prostat_Multipl_2009_417Go to Study
Enhancing the Analytic Capacity of Prostat_AstraZe_2009_144 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
Files:
PROTOCOLClinical Study Protocol redacted.pdf
CRFSample CRF Version 78 5.pdf
DATA DICTIONARYDe indentification RDB standards STUDY14.xlsx
DATA (COMPARATOR ARM)D4320C00014 De-Identified RDB Data.zip
OtherD4320C00014 Format XPT.zip
OtherD4320C00014 Formats.zip